文献速递眼底病与葡萄膜炎小儿眼科与斜弱视

青少年特发性关节炎相关葡萄膜炎的患病率与发病率及TriNetX数据库中的用药趋势

Prevalence and incidence of juvenile idiopathic arthritis-associated uveitis and medication trends in the TriNetX database.
PubMed 文献 · Br J Ophthalmol · 2025-12-15

本研究基于美国TriNetX多中心数据库,通过ICD-10编码识别2013至2023年青少年特发性关节炎相关葡萄膜炎(JIA-U)患者,分析其患病率、发病率、眼部并发症及免疫抑制药物使用趋势。共纳入4510例JIA-U患者,11年累积患病率为4.4/10万,发病率为1.2/10万,二者均随时间下降;JIA患者中5.5%诊断为葡萄膜炎,36.1%的JIA-U患者伴有葡萄膜炎相关眼部不良事件;JIA患者免疫抑制药物使用率逐年上升。

要点

  • 2013至2023年美国JIA-U累积患病率为4.4/10万,发病率为1.2/10万,均呈下降趋势。
  • JIA患者中5.5%诊断为葡萄膜炎,36.1%的JIA-U患者伴有眼部不良事件(包括青光眼、角膜带状变性、低视力和盲)。
  • JIA患者免疫抑制药物使用率在2013至2023年间上升,可能部分解释JIA-U患病率和发病率的下降。

核心结论

  • 在美国大型数据库中,2013至2023年JIA-U的患病率和发病率下降,可能部分归因于JIA患者免疫抑制药物使用率的增加。

研究设计与样本

  • 基于TriNetX大型多中心研究网络数据库,通过国际疾病分类第10版编码识别JIA-U患者,收集2013至2023年11年期间的人口学、并发葡萄膜炎眼部并发症、发病率、患病率、累积患病率及JIA人群免疫抑制药物使用数据。
  • 共纳入4510例JIA-U患者。

主要发现

  • 11年期间JIA-U累积患病率为4.4/10万,发病率为1.2/10万,二者在研究期间均下降。
  • JIA患者中5.5%诊断为葡萄膜炎。
  • 36.1%的JIA-U患者伴有葡萄膜炎相关眼部不良事件,包括青光眼、角膜带状变性、低视力和盲。
  • JIA患者免疫抑制药物治疗的患病率在2013至2023年间上升。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: To investigate the prevalence and incidence of juvenile idiopathic arthritis (JIA)-associated uveitis (JIA-U) in the USA from 2013 to 2023 by analysing the TriNetX database. Secondary outcomes analysed included disease demographics, associated ocular complications and immunosuppressive prescription trends. METHODS: Patients with JIA-U were identified in the TriNetX database, a large, multicentre research network, through International Classification of Diseases, 10th Edition codes. Data collected included patient demographics, concurrent uveitic ocular complications, incidence, prevalence and cumulative prevalence of JIA-U in the 11-year period and immunosuppressive utilisation in the JIA population. RESULTS: 4510 patients with JIA-U were included in this study. The cumulative prevalence and incidence of JIA-U over the 11-year period were 4.4 and 1.2 per 100 000 cases, both of which decreased over the study period. 5.5% of patients with JIA had a diagnosis of uveitis and 36.1% of patients with JIA-U had an associated uveitic ocular adverse event, including glaucoma, band keratopathy, low vision and blindness. The prevalence of immunosuppressive drug therapy in patients with JIA increased over the years 2013-2023. CONCLUSION: In this large US database, the JIA-U prevalence and incidence rates decreased between 2013 and 2023. This may be partially attributed to the increasing prevalence of immunosuppressive drug use in patients with JIA.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Marshall R, Thorne J, Berkenstock MK, et al. Prevalence and incidence of juvenile idiopathic arthritis-associated uveitis and medication trends in the TriNetX database. Br J Ophthalmol. 2025. PMID: 40695571. doi:10.1136/bjo-2024-327087

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。